Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Goldman Sachs Rises Premarket; JPMorgan and Bed Bath & Beyond Fall

Published 04/14/2021, 08:07 AM
Updated 04/14/2021, 08:08 AM
© Reuters.

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Wednesday, April 14th. Please refresh for updates.

  • JPMorgan Chase (NYSE:JPM) stock fell 0.6% despite the investment bank reporting a surge in first-quarter earnings, helped by a strong quarter from its trading desks and soaring investment banking fees. The bank’s stock is up around 70% in the last year. The bottom line was generously inflated by the one-off release of $5.2 billion in reserves.

  • Goldman Sachs (NYSE:GS) stock rose 1.6% after the influential investment bank reported very strong quarterly earnings, with the Wall Street giant cashing in on record levels of deal-making, notably in the craze for SPACs.

  • Wells Fargo (NYSE:WFC) stock rose 0.2% after the bank reported a strong rebound in first-quarter profit, helped by setting aside less money to cover bad loans.

  • Coinbase Global (NASDAQ:COIN) stock will be in focus Wednesday with the world’s second-largest cryptocurrency exchange by volume, set to go public via a direct listing later, with a reference price of $250/share.

  • Bed Bath & Beyond (NASDAQ:BBBY) stock stock fell 9.1% after the retailer reported a double-digit decline in fiscal fourth-quarter sales, with all the company’s stores shut during the pandemic.

  • Dollar General (NYSE:DG) stock fell 0.3% after the discount retailer said it would hire up to 20,000 employees this spring as more parts of the U.S. economy reopen. This is below the more than 50,000 workers the company hired around the same time last year.

  • Moderna (NASDAQ:MRNA) stock rose 3.2% after the drugmaker announced that its Covid-19 vaccine shows above 90% efficacy six months after people have had the second dose. It's also profiting from expectations of higher sales due to problems with Johnson & Johnson (NYSE:JNJ)'s vaccine.

  • Pfizer (NYSE:PFE) stock rose 0.1% after CEO Albert Bourla said the drugmaker has ramped up production of its Covid-19 vaccine and can deliver 10% more doses to the United States by the end of May. This follows the U.S. federal medical regulators pausing the use of Johnson & Johnson’s vaccine over blood clotting worries.

  • Stitch Fix (NASDAQ:SFIX) stock fell 2.2%, continuing Tuesday’s selloff after the online styling service announced that founder Katrina Lake would be stepping down as CEO, to be replaced by the current president, Elizabeth Spaulding, at the start of August.

  • Discovery (NASDAQ:DISCA) stock fell 4.4% and iQIYI (NASDAQ:IQ) stock fell 3.8% after Reuters reported that Credit Suisse (SIX:CSGN) continued to unwind positions related to last month's meltdown of Archegos Capital, including putting large blocks of shares in these two media companies on the market.

  • Endo International (NASDAQ:ENDP) stock rose 0.7% after promising phase 3 data on the pharmaceutical company’s cellulite treatment was published in the official journal of the American Society of Dermatologic Surgery. 

  • Atlassian (NASDAQ:TEAM) stock rose 1.4% after the Australian software company lifted its revenue guidance for the fiscal third quarter, now expecting revenue of between $566 million and $572 million. 

  •  

 

Latest comments

It is amazing in this time that all these corporations are allowed to overstate their earnings and use beneficial accounting practices! The cheating has to stop.
I am sure there is some do toring of numbers but the sheer amount of people involved the scrutiny and speculation hard to flat out cheat without getting caught ask goldman sachs
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.